Home / Inspections / 1270954

FDA Inspection 1270954 — Eurofins Biopharma Product Testing Ireland Limited

Eurofins Biopharma Product Testing Ireland Limited — FEI 3002807550

The FDA completed an inspection of Eurofins Biopharma Product Testing Ireland Limited on May 26, 2023 in Dungarvan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 26, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dungarvan (Ireland)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1280309 (NAI Fri Jun 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1008821 (NAI Fri Feb 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 826551 (NAI Fri Mar 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 618581 (NAI Wed Sep 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources